ACUT — Accustem Sciences Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1850767 ·
Last close
$0.12
Market Cap
$1.93M
52W High
$1.69
52W Low
$0.12
ADV30
4,194
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -350,973 | -252,573 | 1,606,204 | 12,928 | 5,723,821 |
| Mar 2026 | 0 | — | -485,883 | -485,883 | 1,549,532 | 12,207 | 5,421,879 |
| Dec 2025 | 0 | — | -514,388 | -514,388 | 1,549,446 | 13,929 | 4,951,071 |
| Sep 2025 | 0 | — | -399,897 | -399,897 | 1,573,247 | 14,391 | 4,484,157 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-934,383
Investing CF
$0
Financing CF
$910,208
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.10
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,269,026
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-1,801,571
Pretax Income TTM
$-1,801,571
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$98,400
EBITDA
$-1,652,532
Free Cash Flow
$2,105,159
Enterprise Value
$2,492,697
Total Cash
$12,928
Total Debt
$62,641
Shares Out
16,072,267
Trailing EPS
$-0.11
Book Value
$-0.26
ROE
—
ROA
-64.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -1,756,096 | -1,756,096 | 1,549,446 | 4,951,071 | -3,401,625 | -850,389 |
| Dec 2024 | 0 | -1,505,102 | -1,505,102 | 50,851 | 3,364,075 | -3,313,224 | -664,066 |
| Dec 2023 | 0 | -2,050,664 | -2,050,664 | 133,897 | 2,245,477 | -2,111,580 | -1,615,643 |
| Dec 2022 | 0 | -3,746,419 | -3,746,419 | 939,689 | 1,079,239 | -139,550 | -1,806,053 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DCOY | Decoy Therapeutics Inc. | $2.02M | $3.09 | — |
| RNAZ | Transcode Therapeutics, Inc. | $1.79M | $1.69 | — |
| NXTS | Nexentis Technologies Inc. | $2.14M | $1.47 | — |
| PCYN | PROCYON CORP | $2.20M | $0.27 | — |
| OGEN | ORAGENICS INC | $2.21M | $0.49 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.